Using Oral and Colon Cancer Cells for Studying the Anticancer Properties of Antimicrobial Peptides

Teerakul Arpornsuwan1, Wimolpak Sriwai2, Hathaitip Sritanaudomchai3

  • 1Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, 99 PaholyotinRoad, Pathumtani, 12121, Thailand. teerakul@tu.ac.th.

Insights

Antimicrobial peptides show promise as anticancer agents. Researchers investigated their cytotoxic effects on various cell lines, including cancer cells, using the MTT assay.

Area of Science:

  • Biochemistry
  • Immunology
  • Oncology

Background:

  • Antimicrobial peptides (AMPs) are crucial for innate immunity in many organisms.
  • AMPs possess diverse biological functions, including immunomodulation, wound healing, and anti-inflammatory properties.
  • AMPs are explored for therapeutic applications, including as drug delivery vectors and antitumor agents.

Purpose of the Study:

  • To evaluate the anticancer and cytotoxic activities of antimicrobial peptides.
  • To assess the effects of AMPs on specific human cell lines, including cancer and stem cells.

Main Methods:

  • Colorimetric MTT assay was employed to determine cell viability.
  • Experiments were conducted using smooth muscle cells, dental pulp stem cells, human colon cancer cell line (SW620), and human oral squamous carcinoma cell line (HSC4).

Main Results:

  • The study investigated the anticancer and cytotoxic potential of AMPs.
  • Specific results regarding the efficacy against SW620 and HSC4 cell lines were determined via MTT assay.

Conclusions:

  • Antimicrobial peptides demonstrate potential as cytotoxic and anticancer agents.
  • Further research into AMPs could lead to novel cancer therapies.